Actively Recruiting
Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer
Led by Brigitta Rasmussen Villumsen · Updated on 2026-04-01
105
Participants Needed
3
Research Sites
122 weeks
Total Duration
On this page
Sponsors
B
Brigitta Rasmussen Villumsen
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to gather real-world information about Fear of Cancer Recurrence (FCR) following surgery in patients with renal cell carcinoma (RCC) and their partners/spouses by 1) establishing a panel consisting of patients with or without partners/spouses to facilitate patient-partnered research. Furthermore, 2) Through discussions among panel members and researchers identification of the most pertinent topics related to FCR, as well as the optimal timing and methods for collecting that information in the follow-up care after surgery. Finally, to conduct a feasibility and pilot study to investigate the feasibility of the recommendations developed in 1) + 2) and assess FCR in patients with RCC following surgery and their partners/spouses. In phase 1 participants (panel members) will be asked to collaborate with researchers in the development of recommendations for FCR questions, mode of administration and timing in the follow-up care after surgically treated kidney cancer. In phase 2 participants (patients and partners) in follow-up care after surgically treated kidney cancer are asked to answer questions about FCR at specific timepoints defined by panel members and researchers in phase 1.
CONDITIONS
Official Title
Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC in an intimate relationship with a partner/spouse
- Partner/spouse to patients who fulfill the inclusion criteria
- Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)
- Time since surgery: 0-120 months (phase 1)
- Danish speaking patients and partners/spouses able to speak, write and read Danish
- Patients and partners/spouses able and willing to attend online project meetings or in person at Gødstrup Hospital (phase 1)
- Able to receive digital communication from the hospital (phase 2)
- Signed informed consent before answering Fear of Cancer Recurrence questions (phase 2)
You will not qualify if you...
- Diagnosed with cognitive impairment
- Untreated psychiatric disorders due to non-compliance
- Patients and partners/spouses who were panelists in phase 1 (phase 2 only)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Aalborg University Hospital
Aalborg, Denmark, 9000
Actively Recruiting
2
Aarhus University Hospital
Aarhus, Denmark, 8200
Actively Recruiting
3
Gødstrup Hospital
Herning, Denmark, 7400
Actively Recruiting
Research Team
B
Brigitta R Villumsen, PhD
CONTACT
A
Anne H Nielsen, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here